14 Citations (Scopus)

Abstract

YKL-40 is a glycoprotein involved in cellular growth, migration, and the inflammatory process. Elevation in serum levels of YKL-40 has been associated with worse prognosis in various cancers, including breast cancer. Given that the clinical significance of YKL-40 expression in breast cancer tissue is unclear, we aimed to determine the prognostic value of YKL-40 expression in breast cancer tissue using immunohistochemistry. We performed tissue microarray (TMA) analysis of 425 breast cancer tissues collected during operation. Immunohistochemical staining was performed to measure expression of YKL-40 and several breast cancer biomarkers, such as aldehyde dehyadrogenase1, TGF-beta, and Gli-1 as well as hormonal receptor and Her-2/neu status. Statistical analysis of the relationship of YKL-40 expression with clinicopathological characteristics was performed for 390 TMA samples. YKL-40 was expressed to varying degrees in 84.9 % of breast cancer tissues. YKL-40 expression was correlated with estrogen receptor and progesterone receptor negativity and was positively correlated with TGF-beta and Gli-1 expression. Strong YKL-40 expression was associated with a larger proportion of Her-2/neu-enriched and basal-like tumors. The results of this study demonstrate that YKL-40 expression in breast cancer tissues is associated with hormone receptor negativity and Her-2/neu-enriched molecular subtypes of breast cancer, and therefore could be considered a poor prognostic predictor.

Original languageEnglish
Pages (from-to)277-286
Number of pages10
JournalTumor Biology
Volume35
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Breast Neoplasms
Transforming Growth Factor beta1
Tissue Array Analysis
Progesterone Receptors
Tumor Biomarkers
Aldehydes
Estrogen Receptors
Glycoproteins
Immunohistochemistry
Hormones
Staining and Labeling
Growth
Serum
Neoplasms

Keywords

  • Breast cancer
  • Prognostic marker
  • YKL-40

ASJC Scopus subject areas

  • Cancer Research

Cite this

@article{69d88ae419904bb3a7c78b4de8ea2982,
title = "YKL-40 expression could be a poor prognostic marker in the breast cancer tissue",
abstract = "YKL-40 is a glycoprotein involved in cellular growth, migration, and the inflammatory process. Elevation in serum levels of YKL-40 has been associated with worse prognosis in various cancers, including breast cancer. Given that the clinical significance of YKL-40 expression in breast cancer tissue is unclear, we aimed to determine the prognostic value of YKL-40 expression in breast cancer tissue using immunohistochemistry. We performed tissue microarray (TMA) analysis of 425 breast cancer tissues collected during operation. Immunohistochemical staining was performed to measure expression of YKL-40 and several breast cancer biomarkers, such as aldehyde dehyadrogenase1, TGF-beta, and Gli-1 as well as hormonal receptor and Her-2/neu status. Statistical analysis of the relationship of YKL-40 expression with clinicopathological characteristics was performed for 390 TMA samples. YKL-40 was expressed to varying degrees in 84.9 {\%} of breast cancer tissues. YKL-40 expression was correlated with estrogen receptor and progesterone receptor negativity and was positively correlated with TGF-beta and Gli-1 expression. Strong YKL-40 expression was associated with a larger proportion of Her-2/neu-enriched and basal-like tumors. The results of this study demonstrate that YKL-40 expression in breast cancer tissues is associated with hormone receptor negativity and Her-2/neu-enriched molecular subtypes of breast cancer, and therefore could be considered a poor prognostic predictor.",
keywords = "Breast cancer, Prognostic marker, YKL-40",
author = "Kang, {Eun Joo} and Hoiseon Jung and Woo, {Ok Hee} and Park, {Kyong Hwa} and Woo, {Sang- Uk} and Dae-Sik Yang and Aeree Kim and Lee, {Jae Bok} and Kim, {Yeul Hong} and Kim, {Jun Suk} and Seo, {Jae Hong}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s13277-013-1036-0",
language = "English",
volume = "35",
pages = "277--286",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - YKL-40 expression could be a poor prognostic marker in the breast cancer tissue

AU - Kang, Eun Joo

AU - Jung, Hoiseon

AU - Woo, Ok Hee

AU - Park, Kyong Hwa

AU - Woo, Sang- Uk

AU - Yang, Dae-Sik

AU - Kim, Aeree

AU - Lee, Jae Bok

AU - Kim, Yeul Hong

AU - Kim, Jun Suk

AU - Seo, Jae Hong

PY - 2014/1/1

Y1 - 2014/1/1

N2 - YKL-40 is a glycoprotein involved in cellular growth, migration, and the inflammatory process. Elevation in serum levels of YKL-40 has been associated with worse prognosis in various cancers, including breast cancer. Given that the clinical significance of YKL-40 expression in breast cancer tissue is unclear, we aimed to determine the prognostic value of YKL-40 expression in breast cancer tissue using immunohistochemistry. We performed tissue microarray (TMA) analysis of 425 breast cancer tissues collected during operation. Immunohistochemical staining was performed to measure expression of YKL-40 and several breast cancer biomarkers, such as aldehyde dehyadrogenase1, TGF-beta, and Gli-1 as well as hormonal receptor and Her-2/neu status. Statistical analysis of the relationship of YKL-40 expression with clinicopathological characteristics was performed for 390 TMA samples. YKL-40 was expressed to varying degrees in 84.9 % of breast cancer tissues. YKL-40 expression was correlated with estrogen receptor and progesterone receptor negativity and was positively correlated with TGF-beta and Gli-1 expression. Strong YKL-40 expression was associated with a larger proportion of Her-2/neu-enriched and basal-like tumors. The results of this study demonstrate that YKL-40 expression in breast cancer tissues is associated with hormone receptor negativity and Her-2/neu-enriched molecular subtypes of breast cancer, and therefore could be considered a poor prognostic predictor.

AB - YKL-40 is a glycoprotein involved in cellular growth, migration, and the inflammatory process. Elevation in serum levels of YKL-40 has been associated with worse prognosis in various cancers, including breast cancer. Given that the clinical significance of YKL-40 expression in breast cancer tissue is unclear, we aimed to determine the prognostic value of YKL-40 expression in breast cancer tissue using immunohistochemistry. We performed tissue microarray (TMA) analysis of 425 breast cancer tissues collected during operation. Immunohistochemical staining was performed to measure expression of YKL-40 and several breast cancer biomarkers, such as aldehyde dehyadrogenase1, TGF-beta, and Gli-1 as well as hormonal receptor and Her-2/neu status. Statistical analysis of the relationship of YKL-40 expression with clinicopathological characteristics was performed for 390 TMA samples. YKL-40 was expressed to varying degrees in 84.9 % of breast cancer tissues. YKL-40 expression was correlated with estrogen receptor and progesterone receptor negativity and was positively correlated with TGF-beta and Gli-1 expression. Strong YKL-40 expression was associated with a larger proportion of Her-2/neu-enriched and basal-like tumors. The results of this study demonstrate that YKL-40 expression in breast cancer tissues is associated with hormone receptor negativity and Her-2/neu-enriched molecular subtypes of breast cancer, and therefore could be considered a poor prognostic predictor.

KW - Breast cancer

KW - Prognostic marker

KW - YKL-40

UR - http://www.scopus.com/inward/record.url?scp=84893721278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893721278&partnerID=8YFLogxK

U2 - 10.1007/s13277-013-1036-0

DO - 10.1007/s13277-013-1036-0

M3 - Article

C2 - 23918300

AN - SCOPUS:84893721278

VL - 35

SP - 277

EP - 286

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 1

ER -